ReviR Therapeutics leverages AI algorithms and genetic technology to develop RNA-targeting medicines which creates possible cures for tumors, infections and rare diseases.
Yang Li
Founder and Chairman
Revir
Close
Computational BiologyArtificial IntelligenceHealthcare
AI-driven drug developer targeting RNA.
Favorite Innovator
Aristotle